The role of PTPN22 risk variant in the development of autoimmunity: Finding common ground between mouse and human

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 2977-2984

  Rawlings, David J ^a,b   Dai, Xuezhi ^a,b   Buckner, Jane H ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ALLELE; AUTOIMMUNITY; CELL ACTIVATION; CELL LINE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GRAVES DISEASE; HEMATOPOIETIC CELL; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; PTPN22 GENE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASE; DISEASE MODEL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; IMMUNOLOGY; MOUSE; RISK;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK;

EID: 84925858831     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403034     Document Type: Review

References (38)

1. Bottini, N., L. Musumeci, A. Alonso, S. Rahmouni, K. Nika, M. Rostamkhani, J. MacMurray, G. F. Meloni, P. Lucarelli, M. Pellecchia, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338.
2. Begovich, A. B., V. E. Carlton, L. A. Honigberg, S. J. Schrodi, A. P. Chokkalingam, H. C. Alexander, K. G. Ardlie, Q. Huang, A. M. Smith, J. M. Spoerke, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337.
3. Kyogoku, C., C. D. Langefeld, W. A. Ortmann, A. Lee, S. Selby, V. E. Carlton, M. Chang, P. Ramos, E. C. Baechler, F. M. Batliwalla, et al. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75: 504-507.
4. The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), J. B. Harley, M. E. Alarcón-Riquelme, L. A. Criswell, C. O. Jacob, R. P. Kimberly, K. L. Moser, B. P. Tsao, T. J. Vyse, and C. D. Langefeld. 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204-210.
5. Velaga, M. R., V. Wilson, C. E. Jennings, C. J. Owen, S. Herington, P. T. Donaldson, S. G. Ball, R. A. James, R. Quinton, P. Perros, and S. H. Pearce. 2004. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab. 89: 5862-5865.
6. Stanford, S. M., and N. Bottini. 2014. PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol 10: 602-611.
7. Bottini, N., and E. J. Peterson. 2014. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu. Rev. Immunol. 32: 83-119.
8. Cloutier, J. F., and A. Veillette. 1999. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 189: 111-121.
9. Gjörloff-Wingren, A., M. Saxena, S. Williams, D. Hammi, and T. Mustelin. 1999. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 29: 3845-3854.
10. Cloutier, J. F., and A. Veillette. 1996. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15: 4909-4918.
11. de la Puerta, M. L., A. G. Trinidad, Mdel. C. Rodríguez, J. M. de Pereda, M. Sánchez Crespo, Y. Bayón, and A. Alonso. 2013. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling. PLoS ONE 8: e54569.
12. Vang, T., W. H. Liu, L. Delacroix, S. Wu, S. Vasile, R. Dahl, L. Yang, L. Musumeci, D. Francis, J. Landskron, et al. 2012. LYP inhibits T-cell activation when dissociated from CSK. Nat. Chem. Biol. 8: 437-446.
13. Wang, Y., I. Shaked, S. M. Stanford, W. Zhou, J. M. Curtsinger, Z. Mikulski, Z. R. Shaheen, G. Cheng, K. Sawatzke, A. M. Campbell, et al. 2013. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity 39: 111-122.
14. Cohen, S., H. Dadi, E. Shaoul, N. Sharfe, and C. M. Roifman. 1999. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93: 2013-2024.
15. Dai, X., R. G. James, T. Habib, S. Singh, S. Jackson, S. Khim, R. T. Moon, D. Liggitt, A. Wolf-Yadlin, J. H. Buckner, and D. J. Rawlings. 2013. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. Invest. 123: 2024-2036.
16. Zikherman, J., M. Hermiston, D. Steiner, K. Hasegawa, A. Chan, and A. Weiss. 2009. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 182: 4093-4106.
17. Vang, T., M. Congia, M. D. Macis, L. Musumeci, V. Orrú, P. Zavattari, K. Nika, L. Tautz, K. Taskén, F. Cucca, et al. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37: 1317-1319.
18. Aarnisalo, J., A. Treszl, P. Svec, J. Marttila, V. Oling, O. Simell, M. Knip, A. Körner, L. Madacsy, B. Vasarhelyi, et al. 2008. Reduced CD4+ T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J. Autoimmun. 31: 13-21.
19. Rieck, M., A. Arechiga, S. Onengut-Gumuscu, C. Greenbaum, P. Concannon, and J. H. Buckner. 2007. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 179: 4704-4710.
20. Cao, Y., J. Yang, K. Colby, S. L. Hogan, Y. Hu, C. E. Jennette, E. A. Berg, Y. Zhang, J. C. Jennette, R. J. Falk, and G. A. Preston. 2012. High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. PLoS ONE 7: e42783.
21. Vang, T., J. Landskron, M. K. Viken, N. Oberprieler, K. M. Torgersen, T. Mustelin, K. Tasken, L. Tautz, R. C. Rickert, and B. A. Lie. 2013. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses. Hum. Immunol. 74: 574-585.
22. Negro, R., S. Gobessi, P. G. Longo, Y. He, Z. Y. Zhang, L. Laurenti, and D. G. Efremov. 2012. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. Blood 119: 6278-6287.
23. Menard, L., D. Saadoun, I. Isnardi, Y. S. Ng, G. Meyers, C. Massad, C. Price, C. Abraham, R. Motaghedi, J. H. Buckner, et al. 2011. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 121: 3635-3644.
24. Habib, T., A. Funk, M. Rieck, A. Brahmandam, X. Dai, A. K. Panigrahi, E. T. Luning Prak, A. Meyer-Bahlburg, S. Sanda, C. Greenbaum, et al. 2012. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J. Immunol. 188: 487-496.
25. Hasegawa, K., F. Martin, G. Huang, D. Tumas, L. Diehl, and A. C. Chan. 2004. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303: 685-689.
26. Maine, C. J., E. E. Hamilton-Williams, J. Cheung, S. M. Stanford, N. Bottini, L. S. Wicker, and L. A. Sherman. 2012. PTPN22 alters the development of regulatory T cells in the thymus. J. Immunol. 188: 5267-5275.
27. Brownlie, R. J., L. A. Miosge, D. Vassilakos, L. M. Svensson, A. Cope, and R. Zamoyska. 2012. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci. Signal. 5: ra87.
28. Maine, C. J., K. Marquardt, J. Cheung, and L. A. Sherman. 2014. PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells. J. Immunol. 192: 1415-1424.
29. Zheng, P., and S. Kissler. 2013. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant. Diabetes 62: 896-904.
30. Yeh, L. T., S. C. Miaw, M. H. Lin, F. C. Chou, S. J. Shieh, Y. P. Chuang, S. H. Lin, D. M. Chang, and H. K. Sytwu. 2013. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice. J. Immunol. 191: 594-607.
31. Zhang, J., N. Zahir, Q. Jiang, H. Miliotis, S. Heyraud, X. Meng, B. Dong, G. Xie, F. Qiu, Z. Hao, et al. 2011. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat. Genet. 43: 902-907.
32. Wu, D. J., W. Zhou, S. Enouz, V. Orrú, S. M. Stanford, C. J. Maine, N. Rapini, K. Sawatzke, I. Engel, E. Fiorillo, et al. 2014. Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells. PLoS ONE 9: e86677.
33. Wu, J., A. Katrekar, L. A. Honigberg, A. M. Smith, M. T. Conn, J. Tang, D. Jeffery, K. Mortara, J. Sampang, S. R. Williams, et al. 2006. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J. Biol. Chem. 281: 11002-11010.
34. Schnütgen, F., N. Doerflinger, C. Calléja, O. Wendling, P. Chambon, and N. B. Ghyselinck. 2003. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 21: 562-565.
35. Schnütgen, F., and N. B. Ghyselinck. 2007. Adopting the good reFLEXes when generating conditional alterations in the mouse genome. Transgenic Res. 16: 405-413.
36. Chang, H. H., S. C. Miaw, W. Tseng, Y. W. Sun, C. C. Liu, H. W. Tsao, and I. C. Ho. 2013. PTPN22 modulates macrophage polarization and susceptibility to dextran sulfate sodium-induced colitis. J. Immunol. 191: 2134-2143.
37. Spalinger, M. R., S. Lang, A. Weber, P. Frei, M. Fried, G. Rogler, and M. Scharl. 2013. Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes. Gastroenterology 144: 978-988, e10.
38. Hasegawa, K., H. Yajima, T. Katagiri, M. Ogimoto, Y. Arimura, K. Mitomo, K. Mashima, K. Mizuno, and H. Yakura. 1999. Requirement of PEST domain tyrosine phosphatase PEP in B cell antigen receptor-induced growth arrest and apoptosis. Eur. J. Immunol. 29: 887-896.